Table 5

Characteristics of the GC cases

NoSexAge (2002)2002 Baseline histologyTreatment group (2004)GC diagnosis (year)GC typeTNM stage
1M57DYS (low)Celecoxib+placebo2005IntestinalT1
2M64Ind DYSAnti-Hp+placebo2005IntestinalT1
3M48Ind DYSPlacebo2005DiffuseT1
4F63Ind DYSAnti-Hp+celecoxib2005IntestinalT1
5M44IM (deep)Anti-Hp+placebo2006IntestinalT2
6M62Ind DYSAnti-Hp+celecoxib2006IntestinalT1
7M51Ind DYSCelecoxib+placebo2006IntestinalT1
8M57DYS (low)Anti-Hp+celecoxib2007IntestinalT2
9M41Ind DYSAnti-Hp+placebo2007IntestinalT1
  • Anti-Hp, anti-H pylori treatment; CAG, chronic atrophic gastritis; DYS, dysplasia; F, female; GC, gastric cancer; IM, intestinal metaplasia; Ind DYS, indefinite dysplasia; M, male; TNM, tumour, node, metastases.